AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

The human body is teeming with trillions of symbiotic microorganisms, profoundly impacting our well-being. Within the gut, ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Lung cancer is one of the leading causes of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about ...

Scientists from Rice University and their collaborators have unveiled a groundbreaking technique to combat cancer cells, ...

The program has shown strong ... Outside-in Signaling Shows a Route Into Cancer Cells Feb. 4, 2025 — A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked ...

A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug ...